June 9, 2014
(NYSE: PHG AEX: PHIA) today introduced
PET/CT, the first digital PET/CT scanner, at the 2014 annual meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI), taking place this week in
, Mo. In addition to Vereos, Philips will showcase a selection of innovative, molecular imaging solutions designed to deliver outstanding image quality, critical clinical information and greater connectivity.
PET/CT uses innovative digital silicon photomultiplier detectors instead of traditional analog detectors, creating a step change in performance that includes approximately two-times increase in sensitivity gain, volumetric resolution and quantitative accuracy compared to analog systems.* These improvements can ultimately be translated into high image quality, increased diagnostic confidence, improved treatment planning and faster workflows.
"From connected devices to data-driven insights, the pace of imaging innovation is allowing us to see more," said
, chief executive officer, Imaging Systems, Philips. "Molecular imaging technology is leading the way with digital detection and advanced visualization built on insights from those at the heart of care."
Visitors to the Philips Booth (#1521) at SNMMI will have the opportunity to interact with Vereos digital PET/CT clinical images and technology using engaging 3D visualization tools. This unique experience provides clinicians an understanding of how Vereos can be used to deliver customized care to meet their most pressing needs.
During the SNMMI annual meeting, Philips will also host a series of three "Innovation Talks" in its booth theater area on
Monday, June 9
. These sessions will spotlight customers, scientists and industry thought leaders who will discuss topics related to the current and future landscape for digital PET, patient-centered imaging, and the importance of creating customized workflows to help manage patient care and radiation dose. Each of the "Innovation Talks" sessions will last 15 minutes and is open to all event attendees.
In addition to Vereos, Philips will showcase a selection of its advanced molecular imaging technology solutions that help contribute to a 360-degree view of the patient and offer increased diagnostic confidence. Designed to provide access to the right data at the right time, these solutions seamlessly exchange health information data, and interpret the data that matters most to help improve patient outcomes and save lives.